Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
2005 Standout
Facilitating equitable prevention and management of gout for Māori in Northland, New Zealand, through a collaborative primary care approach
2019
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
2010
Comorbidities in patients with gout prior to and following diagnosis: case-control study
2014
Depression
2018 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Pilot study of a multidisciplinary gout patient education and monitoring program
2016
Benefit-Risk Assessment of Leflunomide
2009
Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis
2009
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Revisiting comorbidities in gout: a cluster analysis
2013
Rheumatoid arthritis
2016 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
Abnormal intestinal intraepithelial lymphocytes in refractory sprue
1998
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies
2017
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Juvenile idiopathic arthritis
2007 Standout
Exercise Standards for Testing and Training
2013 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Physiology of natriuretic peptides
1994
Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study
2014
The Aging Kidney: A Review – Part I
2005
Gout
2009 Standout
Diagnostic accuracy of ultrasound in patients with gout: A meta-analysis
2017
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
2014
Celiac Disease
2007 Standout
Chronic kidney disease
2011 Standout
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
2016 Standout
Forget personalised medicine and focus on abating disease activity
2012
Targeting the NLRP3 inflammasome in inflammatory diseases
2018
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
2006
The IL-1 family of cytokines and receptors in rheumatic diseases
2019
The unclosing premature mortality gap in gout: a general population-based study
2017
Psoriasis
2015 Standout
Epidemiology and management of gout in Taiwan: a nationwide population study
2015
The immune system in atherosclerosis
2011 Standout
Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing
2011
Update on gout: new therapeutic strategies and options
2010
Gout
2016 Standout
Enhancing the Stability and Solubility of the Glucocorticoid Receptor Ligand-Binding Domain by High-Throughput Library Screening
2010
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
2012
FireProt: Energy- and Evolution-Based Computational Design of Thermostable Multiple-Point Mutants
2015 StandoutNobel
TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis
2011
Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors
2013
Diagnostic accuracy of dual-energy computed tomography in patients with gout: A meta-analysis
2017
European biologicals registers: methodology, selected results and perspectives
2008
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method
2000
Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial
2018
Rheumatoid arthritis
2010 Standout
Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial
2018
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study
2018
The Inflammasomes
2010 Standout
Efficacy and Tolerability of Probenecid as Urate-lowering Therapy in Gout; Clinical Experience in High-prevalence Population
2013
Defining trained immunity and its role in health and disease
2020 Standout
Current management of juvenile idiopathic arthritis
2006
Sarcoidosis
2007 Standout
Atrial natriuretic peptide attenuates the development of pulmonary hypertension in rats adapted to chronic hypoxia.
1990
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment
2010
Inflammation in obesity, diabetes, and related disorders
2022 Standout
A patient with arthritis, severe back pain, impaired wound healing, and perforated sigmoid colon
2006
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
Targeting SHIP-1 in Myeloid Cells Enhances Trained Immunity and Boosts Response to Infection
2018
Immunobiography and the Heterogeneity of Immune Responses in the Elderly: A Focus on Inflammaging and Trained Immunity
2017
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Calcium-dependent Dephosphorylation Mediates the Hyperosmotic and Lysophosphatidic Acid-dependent Inhibition of Natriuretic Peptide Receptor-B/Guanylyl Cyclase-B
2004
Global epidemiology of gout: prevalence, incidence and risk factors
2015 Standout
Steroid-resistant sarcoidosis: is antagonism of TNF-α the answer?
2007
Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy
2002 StandoutNobel
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets
2015
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Application of a Novel Diagnostic Rule in the Differential Diagnosis between Acute Gouty Arthritis and Septic Arthritis
2015
Pulmonary vasodilatory action of endogenous atrial natriuretic factor in rats with hypoxic pulmonary hypertension. Effects of monoclonal atrial natriuretic factor antibody.
1992
Introduction to the human gut microbiota
2017 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
Cost-Effectiveness of Allopurinol and Febuxostat for the Management of Gout
2014
Etanercept for the treatment of rheumatoid arthritis
2013
Etanercept for the Treatment of Rheumatoid Arthritis
2018
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Gout
2021 Standout
Molecular Imprinted Polymer Based Thermo-Sensitive Electrochemical Sensor for Theophylline Recognition
2013
Medication Adherence in Gout: A Systematic Review
2014
Exercise for intermittent claudication
2017
Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space
2016
Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication
2013
Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States
2011
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Industry sponsorship and research outcome
2017 Standout
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Molecular imprinting: perspectives and applications
2016 Standout
Works of Tim Jansen being referenced
Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study
2011
Authors' reply: A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable?
2005
Rasburicase treatment in severe tophaceous gout: a novel therapeutic option
2005
Leflunomide in active rheumatoid arthritis: a prospective study in daily practice
2004
Leflunomide for the Treatment of Rheumatoid Arthritis in Clinical Practice
2004
Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients
2007
Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation
2005
Gout: why is this curable disease so seldom cured?
2012
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout
2008
Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra
2015
The potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis
2011
New classification criteria for gout: a framework for progress
2013
Improving cardiovascular and renal outcomes in gout: what should we target?
2014
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol
2008
EULAR recommendations for calcium pyrophosphate deposition. Part II: Management
2011
Gout
2009
Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial
2020
Effectiveness of a Third Tumor Necrosis Factor-α-blocking Agent Compared with Rituximab After Failure of 2 TNF-blocking Agents in Rheumatoid Arthritis
2011
Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases
2015
Additive value for ultrasonographic signal in a screening algorithm for patients presenting with acute mono-/oligoarthritis in whom gout is suspected
2014
Imaging modalities for the classification of gout: systematic literature review and meta-analysis
2014
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial
2015
Glucocorticosteroids in the management of rheumatoid arthritis
1999
Leflunomide in active rheumatoid arthritis: a prospective study in daily practice
2004
Management of hyperuricemia in gout: focus on febuxostat
2010
The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice
2007
Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatment.
2005
Coeliac disease and lymphoma
1991
Study of Prepolymerization Complex Formation in the Synthesis of Steroid-Based Molecularly Imprinted Polymers
2012
A comparison of the vasodilator responses to atrial peptides in the pulmonary and renal arteries of the pig in vitro
1987
Kinetics of atrial natriuretic peptide in young and elderly subjects
1992
Benzbromarone withdrawn from the European market: another case of "absence of evidence is evidence of absence"?
2004
[Effect of a 2-year ambulatory vascular sports program on walking distance in claudication patients--a controlled study].
1991
Atrial Natriuretic Factor Potentiates the Human Forearm Vasoconstrictor Response to Sympathetic Stimulation
1994
P160 The first phase 2A proof-of-concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile™ (OLT1177™), in acute gout
2019
Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial
2018
P159/O30 OLT1177™, an oral NLRP3 inflammasome inhibitor, inhibits acute joint inflammation and circulating IL 1β during gout flares in humans
2019
Impaired Vasodilator Response to Atrial Natriuretic Factor in IDDM
1993